Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2001 | 06-2000 | 06-1999 | 06-1996 | 06-1994 | |
| Assets | |||||
| Current Assets | |||||
| Inventories | 8,640 | 8,420 | 8,900 | 2,599 | 2,147 |
| Other current assets | 6,230 | 4,750 | 3,170 | 757 | 325 |
| TOTAL | $14,870 | $13,170 | $12,070 | $3,356 | $2,471 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5,590 | 4,610 | 2,427 | 738 |
| Other Non-Current Assets | 11,830 | 12,410 | 1,200 | 0 | 0 |
| TOTAL | $11,830 | $18,000 | $5,810 | $2,427 | $738 |
| Total Assets | $26,700 | $31,170 | $17,880 | $5,783 | $3,209 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,430 | 2,170 | 1,240 | 294 | N/A |
| Accounts payable and accrued liabilities | 3,970 | 3,100 | 2,030 | 530 | 243 |
| Accrued Expenses | 5,830 | 3,360 | 2,650 | 506 | 530 |
| Other current liabilities | 0 | 1,670 | 0 | 0 | N/A |
| TOTAL | $12,230 | $13,170 | $8,320 | $1,885 | $1,144 |
| Non-Current Liabilities | |||||
| TOTAL | $350 | $580 | $240 | $N/A | $N/A |
| Total Liabilities | $12,580 | $13,750 | $8,560 | $1,885 | $1,144 |
| Shareholders' Equity | |||||
| Common Shares | 1,070 | 1,050 | 1,040 | 467 | 453 |
| Other shareholders' equity | -1,060 | -360 | -230 | 0 | 0 |
| TOTAL | $21,430 | $21,560 | $21,550 | $5,731 | $5,438 |
| Total Liabilities And Equity | $34,010 | $35,310 | $30,110 | $7,616 | $6,583 |